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Introduction:
Effective tight glycemic control (TGC) can improve outcomes, particularly in cardiovascular surgery, but is 
difficult to achieve. Variability in insulin sensitivity/resistance resulting from the level and evolution of stress 
response, particularly early in a patient’s stay, can lead to hyperglycemia and variability, which are associated 
with mortality. This study quantifies the daily evolution of the variability of insulin sensitivity for cardiovascular 
surgical and all other ICU patients. 
Methods:
Retrospective analysis of SPRINT TGC study data. Model-based insulin sensitivity (SI) was identified hourly 
from data. Hour-to-hour percent changes in SI were assessed for cardiovascular surgical (CVS) patients (N=76) 
and all other, non-cardiovascular surgery (Non-CVS) patients (N=317). Results are compared for Days 1, 2, 3 and 
Days 4 Onward. Cumulative distribution functions (CDFs), median values, and inter-quartile points (25th and 
75th percentiles) are used to assess differences between groups and their evolution over time. 
Results:
CVS patients are more variable than Non-CVS patients on Days 1-2 (p<0.005) and similar on Days 3 and 4 
Onward (p≥0.13). Variability declines by day. CVS and Non-CVS patients are both more variable on each of Days 
1-3 than the overall Day 4 Onward values (p<0.005). At the inter-quartile percentiles, CVS patients are 1.4-2.0 
times more variable than Non-CVS patients on Day 1, 1.40-1.44 times on Day 2, and 1.1-1.2 times on Day 3, but 
identical (<1.1x difference) for Day 4 Onward. Absolute SI increases daily for both groups, and the difference 
between groups shrinks from 33% to 12% over Days 1-3 and is 4% on Day 4 onward (p<0.005 for all). Glycemic 
control was equivalent for both groups (p>0.05) and thus these results were not due to differences in TGC 
achieved, but patient-specific factors instead. 
Conclusions:
All ICU patients exhibit greater insulin sensitivity variability over Days 1-3, and cardiovascular surgery patients 
are more variable than others. Clinically, the results imply that TGC patients, especially cardiovascular surgery 
patients, will require greater measurement frequency, reduced reliance on insulin, and more explicit specification 
of carbohydrate nutrition in Days 1-3 to safely minimise glycemic variability and maximise control for best 
outcome. 
